Case Report
BibTex RIS Cite

Böbrek fonksiyon bozukluğu olan iki hastada linezolide bağlı trombositopeni

Year 2016, Volume: 41 Issue: 4, 808 - 810, 31.12.2016
https://doi.org/10.17826/cutf.254552

Abstract

Linezolid, glikopeptidlerde dahil diğer antibiyotiklere dirençli gram pozitif bakterilere karşı etkin olan oksazolidinon grubu bir antibiyotiktir. Linezolid kullanımına bağlı görülen yan etkilerden birisi trombositopenidir. Trombositopeniye neden olan farklı birçok risk faktörü bildirilmesine karşın, bu yan etkinin nedeni tam olarak bilinmemektedir. Burada kliniğimizde kronik böbrek hastalığı tanısı ile izlenen ve linezolid tedavisi sırasında trombositopeni gelişen iki vakayı sunduk. Bu vakaları sunmaktaki amacımız linezolidin bu yan etkisi hakkında farkındalığı artırmaktır. Çünkü, linezolid tedavisi sırasında trombositopeni görülebileceği çok iyi bilinmesine karşın, bu yan etkinin gelişme riskinin böbrek fonksiyon bozukluğu olanlarda olmayanlara göre daha yüksek olduğu bilinmemektedir.


References

  • 1. Natsumoto B, Yokota K, Omata F, Furukawa K. Risk factors for linezolid-associated thrombocytopenia in adult patients. Infection. 2014;42:1007-12.

Linezolid-induced thrombocytopenia in two patients with renal dysfunction

Year 2016, Volume: 41 Issue: 4, 808 - 810, 31.12.2016
https://doi.org/10.17826/cutf.254552

Abstract

Linezolid is an oxazolidinone antibiotic, active against gram positive bacteria that are resistant to other antibiotics including glycopeptides. Thrombocytopenia is an adverse effect of linezolid. Although various risk factors have been suggested, the mechanisms behind this side effect are largely unknown. Here, we report two adolescents with the diagnosis of chronic kidney disease who developed thrombocytopenia following treatment with linezolid. Our purpose in highlighting these cases is to increase the clinical awareness concerning this side effect of linezolid. While it is well known that thrombocytopenia may develop during linezolid treatment, it is relatively unknown that patients with renal dysfunction have an increased risk for the development of thrombocytopenia compared to patients without renal dysfunction.


References

  • 1. Natsumoto B, Yokota K, Omata F, Furukawa K. Risk factors for linezolid-associated thrombocytopenia in adult patients. Infection. 2014;42:1007-12.
There are 1 citations in total.

Details

Subjects Health Care Administration
Journal Section Case Report
Authors

Engin Melek This is me

Bahriye Atmış This is me

Aysun Karabay Bayazıt This is me

Ali Anarat This is me

Publication Date December 31, 2016
Acceptance Date April 18, 2016
Published in Issue Year 2016 Volume: 41 Issue: 4

Cite

MLA Melek, Engin et al. “Linezolid-Induced Thrombocytopenia in Two Patients With Renal Dysfunction”. Cukurova Medical Journal, vol. 41, no. 4, 2016, pp. 808-10, doi:10.17826/cutf.254552.